Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
INVISIO | IVSO | Oct 31, 2024 | 268.00 | +2.29 |
Invoicery Group AB | FRILAN | Oct 31, 2024 | 3.80 | -0.52 |
Inwido | INWI | Oct 31, 2024 | 193.40 | -0.62 |
Irisity | IRIS | Oct 31, 2024 | 1.17 | -3.31 |
IRLAB Therapeutics A | IRLABA | Oct 31, 2024 | 12.60 | -1.95 |
Isofol Medical | ISOFOL | Oct 31, 2024 | 3.78 | +1.48 |
ITAB Shop Concept | ITAB | Oct 31, 2024 | 26.00 | -4.06 |
iZafe Group B | IZAFEB | Oct 31, 2024 | 0.23 | +3.60 |
Jetpak Top Holding | JETPAK | Oct 31, 2024 | 106.00 | 0.00 |
JLT Mobile Computers | JLT | Oct 31, 2024 | 3.06 | -1.92 |
JM | JM | Oct 31, 2024 | 179.30 | -0.22 |
Job Solution Sweden Holding AB (publ) | JOBS | Oct 31, 2024 | 23.00 | 0.00 |
John Mattson | JOMA | Oct 31, 2024 | 65.80 | +0.61 |
JonDeTech Sensors | JDT | Oct 31, 2024 | 2.58 | -9.79 |
JS Security | JSSEC | Oct 31, 2024 | 0.10 | +5.51 |
Jumpgate | GATE | Oct 31, 2024 | 4.60 | +15.00 |
K-Fast Holding B | KFASTB | Oct 31, 2024 | 21.85 | -0.91 |
K2A Knaust & Andersson Fastigheter B | K2AB | Oct 31, 2024 | 12.10 | -2.42 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Oct 31, 2024 | 197.00 | -1.01 |
KABE Group B | KABEB | Oct 31, 2024 | 319.00 | -1.54 |
Kakel Max | KAKEL | Oct 31, 2024 | 10.20 | 0.00 |
Kallebäck Property Invest | KAPIAB | Oct 31, 2024 | 179.50 | +0.28 |
Kambi Group | KAMBI | Oct 31, 2024 | 135.20 | +2.58 |
Kancera | KAN | Oct 31, 2024 | 1.70 | -0.93 |
Karnell Group AB (publ) | KARNELB | Oct 31, 2024 | 44.36 | +1.30 |
Karnov Group | KAR | Oct 31, 2024 | 79.60 | +0.25 |
Karolinska Development B | KDEV | Oct 31, 2024 | 1.21 | +0.17 |
Katalysen Ventures AB | KAV | Oct 31, 2024 | 12.10 | 0.00 |
KebNi B | KEBNIB | Oct 31, 2024 | 1.00 | -6.54 |
Kentima Holding B | KENH | Oct 31, 2024 | 2.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.